Tokio Marine Asset Management Co. Ltd. decreased its stake in shares of UnitedHealth Group Inc. (NYSE:UNH) by 2.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 110,122 shares of the healthcare conglomerate’s stock after selling 2,483 shares during the period. UnitedHealth Group makes up approximately 1.6% of Tokio Marine Asset Management Co. Ltd.’s holdings, making the stock its 10th largest position. Tokio Marine Asset Management Co. Ltd.’s holdings in UnitedHealth Group were worth $15,549,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of UNH. Bank of Montreal Can bought a new position in shares of UnitedHealth Group during the second quarter worth approximately $207,013,000. Dodge & Cox increased its position in shares of UnitedHealth Group by 9.6% in the first quarter. Dodge & Cox now owns 15,183,189 shares of the healthcare conglomerate’s stock worth $1,957,113,000 after buying an additional 1,324,136 shares during the last quarter. Prudential Financial Inc. increased its position in shares of UnitedHealth Group by 47.4% in the first quarter. Prudential Financial Inc. now owns 2,458,710 shares of the healthcare conglomerate’s stock worth $316,927,000 after buying an additional 790,220 shares during the last quarter. NN Investment Partners Holdings N.V. bought a new position in shares of UnitedHealth Group during the first quarter worth approximately $83,434,000. Finally, UBS Asset Management Americas Inc. increased its position in shares of UnitedHealth Group by 13.0% in the first quarter. UBS Asset Management Americas Inc. now owns 4,424,657 shares of the healthcare conglomerate’s stock worth $570,338,000 after buying an additional 508,995 shares during the last quarter. 85.78% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.24% on Tuesday, hitting $138.16. The stock had a trading volume of 2,452,575 shares. The firm’s 50 day moving average is $138.21 and its 200-day moving average is $136.26. The stock has a market capitalization of $131.58 billion, a PE ratio of 21.62 and a beta of 0.57. UnitedHealth Group Inc. has a one year low of $107.51 and a one year high of $144.48.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, topping analysts’ consensus estimates of $1.89 by $0.07. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. The business earned $46.50 billion during the quarter, compared to analysts’ expectations of $45.05 billion. Equities research analysts expect that UnitedHealth Group Inc. will post $7.90 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were issued a dividend of $0.625 per share. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 annualized dividend and a yield of 1.81%. UnitedHealth Group’s dividend payout ratio is presently 39.12%.

A number of research analysts recently commented on UNH shares. Leerink Swann restated a “buy” rating on shares of UnitedHealth Group in a research note on Friday, June 10th. Credit Suisse Group AG reissued a “buy” rating on shares of UnitedHealth Group in a research note on Friday, June 10th. Sanford C. Bernstein assumed coverage on UnitedHealth Group in a research note on Wednesday, June 15th. They issued an “outperform” rating and a $171.00 price target for the company. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, June 21st. Finally, Wolfe Research assumed coverage on UnitedHealth Group in a research note on Tuesday, June 28th. They issued an “outperform” rating and a $172.00 price target for the company. One equities research analyst has rated the stock with a hold rating, twenty-four have assigned a buy rating and one has given a strong buy rating to the company. The stock has an average rating of “Buy” and an average price target of $155.35.

In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares in the company, valued at $271,100,350.50. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.65% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.